These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22114778)
1. Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder. Elia J; Wilson Z; La Porta LS; Algon SA; Prowler ML; Cartwright ST; McKenna PA; Laracy S; Takeda T; Borgmann-Winter K Expert Rev Clin Pharmacol; 2011 May; 4(3):311-28. PubMed ID: 22114778 [TBL] [Abstract][Full Text] [Related]
2. Transdermal methylphenidate system: old wine in a new bottle. Bukstein OG Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029 [TBL] [Abstract][Full Text] [Related]
3. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143 [TBL] [Abstract][Full Text] [Related]
4. Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting. Warshaw EM; Paller AS; Fowler JF; Zirwas MJ Clin Ther; 2008 Feb; 30(2):326-37. PubMed ID: 18343271 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting. Pelham WE; Waxmonsky JG; Schentag J; Ballow CH; Panahon CJ; Gnagy EM; Hoffman MT; Burrows-MacLean L; Meichenbaum DL; Forehand GL; Fabiano GA; Tresco KE; Lopez-Williams A; Coles EK; González MA J Atten Disord; 2011 Jan; 15(1):28-35. PubMed ID: 20439487 [TBL] [Abstract][Full Text] [Related]
6. Methylphenidate transdermal system. Mays DA; Findling R J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112 [No Abstract] [Full Text] [Related]
7. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664 [TBL] [Abstract][Full Text] [Related]
8. Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder. Ashkenasi A Pediatr Neurol; 2011 Dec; 45(6):381-6. PubMed ID: 22115000 [TBL] [Abstract][Full Text] [Related]
9. Effects of application to two different skin sites on the pharmacokinetics of transdermal methylphenidate in pediatric patients with attention-deficit/hyperactivity disorder. González MA; Campbell D; Rubin J J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):227-32. PubMed ID: 19519257 [TBL] [Abstract][Full Text] [Related]
10. Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS). Findling RL; Dinh S CNS Drugs; 2014 Mar; 28(3):217-28. PubMed ID: 24532028 [TBL] [Abstract][Full Text] [Related]
15. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. Pelham WE; Manos MJ; Ezzell CE; Tresco KE; Gnagy EM; Hoffman MT; Onyango AN; Fabiano GA; Lopez-Williams A; Wymbs BT; Caserta D; Chronis AM; Burrows-Maclean L; Morse G J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):522-9. PubMed ID: 15908834 [TBL] [Abstract][Full Text] [Related]
16. Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children. Anderson VR; Scott LJ Drugs; 2006; 66(8):1117-26. PubMed ID: 16789796 [TBL] [Abstract][Full Text] [Related]
17. Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system. Heal DJ; Pierce DM CNS Drugs; 2006; 20(9):713-38. PubMed ID: 16953648 [TBL] [Abstract][Full Text] [Related]
18. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder. Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602 [TBL] [Abstract][Full Text] [Related]
19. Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder. Pierce D; Katic A; Buckwalter M; Webster K J Clin Psychopharmacol; 2010 Oct; 30(5):554-64. PubMed ID: 20814325 [TBL] [Abstract][Full Text] [Related]
20. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]